• Aucun résultat trouvé

1 MARSEILLESIRIC SYMPOSIUM ST

N/A
N/A
Protected

Academic year: 2022

Partager "1 MARSEILLESIRIC SYMPOSIUM ST"

Copied!
1
0
0

Texte intégral

(1)

1 ST MARSEILLE

SIRIC SYMPOSIUM

1 st of October 2014

Institut Paoli-Calmettes - Marseille

9h / Welcome address - presentation of the Marseille SIRIC Pr Patrice Viens, Director of Institut Paoli-Calmettes and of the Marseille SIRIC

9h15 / Targeting breast cancer stem cells

Pr Emmanuelle Charafe-Jauffret, Center for Cancer Research of Marseille 9h35 / Patient-derived breast cancer xenografts as a platform for drug development and personalized medicine

Pr Michael T Lewis, Baylor College, Houston, Texas 10h15 / Spatial and temporal genetic heterogeneity reveals the evolutionary history of lung cancer Dr Elza de Bruin, University College London

11h / Coffee break

11h15 / Insular gliomas, an integrated approach

Pr Philippe Metellus, Center for Oncobiology and Oncopharmacology, Marseille

11h35 / The POLA network : an exemple of the structuration of rare adult cancer in France Pr Jean-Yves Delattre, Pitié-Salpétrière Hospital, Paris

12h15 / Lunch

14h / Organization of patient care and patient preferences regarding local care units vs technical platforms

Drs Nora Moumjid and Valérie Buthion, Université Claude Bernard, Lyon 14h20 / An immunogenic onco-glycoprotein common to human and murine pancreatic tumors: a candidate for dendritic cell vaccination Dr Evelyne Béraud, Center for Oncobiology and Oncopharmacology, Marseille

14h40 / Pancreatic Cancer: From Molecular Understanding to Personalized Medicine Dr Manuel Hidalgo, National Center for Oncological Investigations, CNIO, Madrid

15h20 / A chemico-genomic approach to AML therapy Pr Norbert Vey, Institut Paoli-Calmettes, Marseille

15h40 / Leukemia, chromosome translocations, and the unforeseen liaison with mTOR signaling Pr Gerard Grosveld, St Jude Research Hospital 16h20 / Coffee break

16h35 / Restart: grafted patients support association Mélanie Riegel

16h50 / Brain tumor research association Dominique David

17h05 / Conclusion Pr Patrice Viens

CONTACT AND REGISTRATION Registration is free but compulsory Contact : Valérie Depraetere-Ferrier E-mail : depraeterev@ipc.unicancer.fr

VENUE Institut Paoli-Calmettes Conference room, IPC2 building (Centre d’Information,

de Prévention et de Consultation en Cancérologie) 15, boulevard Leï Roure - 13009 Marseille

Direction de la communication - Institut Paoli-Calmettes - 05/2014

Références

Documents relatifs

An intervention directed to all attempters after self-harm or suicidal behaviours has been suggested to be the only method for achieving a reduction of suicide risk (Owens et

Under the assumption that the joint distribution has a density that is continuous in A ; B and C, we provide necessary and sufficient conditions under which the intersection

لﯾﻠﻌﺗﻟا ﻰﻘﺑﯾو Motivation ﺔﻋوﻣﺟﻣﻟ ادﻧﺳ دﻌﺗ ﻲﺗﻟاو ﺔﯾﺻﺧﺷﻟا رود ﺔﻣﯾﻗ ﻰﻠﻋ ﺔﯾﻟﺎﺗﻟا قرطﻟا ﻊﺑﺗﺗﯾ ﺎﻣﻛ ،ﻲﺋﺎﻛﺣﻟا صﻧﻟا ﻲﻓ ةرﻓوﺗﻣﻟا تارﺎﯾﺧﻟا نﻣ : أ -

In this work, we have shown that deletion of UPF1 does not affect ade1-14 mRNA level, but results in allosuppres- sion of ade1-14 mutation in sup45 nonsense mutants

The theory is developed in three steps. First, the limiting cases of axial compression and planar bending are constructed analytically and numerically to serve as

Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.. Ann

progesterone receptor; RTV: relative tumor volume; SCNA: somatic copy number alteration; SMG: signi fi cantly mutated gene; TBP: Tata box bind- ing protein; TCGA: The Cancer

We and others recently demonstrated that the microenvironment is critical for ER + tumor cells; when grafted as single cells into milk ducts of NOD Scid gamma (NSG) females